CLINICAL_TRIALS
trial_result
· 2012-08-30
Clinical Trial Update: POWER (Pulse Width Optimized Waveform Evaluation Trial) [Phase 4]
Summary
Phase 4 trial POWER evaluated Pulse Width Optimized Waveform for preventing sudden cardiac death; results were posted after completion in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Abbott Medical Devices | Conditions: Sudden Cardiac Death | Phase 4 | Status: COMPLETED | Results posted: 2012-08-30